Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of Nerve Regeneration After Nerve Transsection Using (Diffusion-tensor Magnetic Resonance Imaging) DTI MR Imaging

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by University of Zurich.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01020149
First received: November 23, 2009
Last updated: June 24, 2010
Last verified: June 2010
  Purpose

To prospectively evaluate the nerve regeneration after traumatic nerve transsection using diffusion tensor magnetic resonance imaging (DTI MR imaging).


Condition Intervention
Nerve Degeneration
Other: MR Imaging

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 15
Study Start Date: January 2010
Estimated Study Completion Date: December 2012
Intervention Details:
    Other: MR Imaging
    MRI is used to evaluate nerve regeneration after traumatic transsection and nerve repair.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

primary care clinic

Criteria

Inclusion criteria:

  • Patients with traumatic nerve transsection and nerve repair.

Exclusion criteria:

  • contraindication for MRI;
  • pregnancy;
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01020149

Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

No publications provided

Responsible Party: Dr. Gustav Andreisek, Institute for Diagnostic Radiology
ClinicalTrials.gov Identifier: NCT01020149     History of Changes
Other Study ID Numbers: 003
Study First Received: November 23, 2009
Last Updated: June 24, 2010
Health Authority: Switzerland: Swissmedic

Keywords provided by University of Zurich:
Nerve transsection

Additional relevant MeSH terms:
Nerve Degeneration
Pathologic Processes

ClinicalTrials.gov processed this record on November 20, 2014